Please use this identifier to cite or link to this item:
http://repositorio.insp.mx:8080/jspui/handle/20.500.12096/7755Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.coverage.spatial | nacional | |
| dc.creator | Soto Noguerón, Araceli | |
| dc.date.accessioned | 2022-02-16T04:20:50Z | - |
| dc.date.available | 2022-02-16T04:20:50Z | - |
| dc.date.issued | 2018 | |
| dc.identifier.uri | sicabi.insp.mx:2018-None | |
| dc.identifier.uri | http://saludpublica.mx/index.php/spm/article/view/8159 | |
| dc.identifier.uri | https://www.doi.org/10.21149/8159 | |
| dc.identifier.uri | http://repositorio.insp.mx:8080/jspui/handle/20.500.12096/7755 | - |
| dc.description.abstract | To describe the distribution of pneumococcal serotypes causing infectious diseases in patients with hematological malignancies and solid tumors and their antimicrobial susceptibility before and after introduction of pneumococcal conjugate vaccine (PCV7) in Mexico. Materials and methods: Consecutive pneumococcal isolates from hospitalized patients from the SIREVA-network were serotyped using the Quellung reaction and antimicrobial susceptibility was performed using the broth microdilution method. Results: A total of 175 pneumococcal isolates were recovered, 105 from patients with hematological malignancies and 70 with solid tumors. Serotypes 19A (22.7%), 19F (20.4%), and 35B (17.7%) were the most frequent isolates in the first group and serotypes 3 (27.2%) and 19A (28.6%) in the second group. No decreased susceptibility to beta-lactams or TMP/SMX was observed after introduction of PCV7. Conclusions: An increase in non-vaccine types is observed without significate changes in antimicrobial susceptibility after introduction of PCV7. | |
| dc.format | ||
| dc.language | spa | |
| dc.publisher | ESPM INSP | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0 | |
| dc.subject | AdolescentAdultAgedAged, 80 and overChildChild, PreschoolCross Infection epidemiologyCross Infection microbiology,Drug Resistance, Multiple, BacterialFemaleHeptavalent Pneumococcal Conjugate VaccineHumansImmunocompromised HostMaleMexico epidemiologyMiddle AgedNeoplasms complicationsOpportunistic Infections complicationsOpportunistic Infections epidemiologyOpportunistic Infections microbiology,SerogroupStreptococcal Infections complicationsStreptococcal Infections microbiologyStreptococcus pneumoniae classificationStreptococcus pneumoniae drug effectsStreptococcus pneumoniae isolation purificationVaccinationYoung Adult,Streptococcus pneumoniae, antiinfective agents cancer vaccines | |
| dc.title | Streptococcus pneumoniae: distribution of serotypes and antimicrobial susceptibility in patients with cancer | |
| dc.type | info:eu-repo/semantics/article | |
| dc.subject.cti | info:eu-repo/classification/cti/3 | |
| dc.creator.orcid | orcid/0000-0001-5091-962X;Soto Noguerón, Araceli | |
| Appears in Collections: | Artículos | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.